Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 12/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 10/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ECE1 | P42892 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590556 | 0.99 | OPRD1 (0.39) | OPRD1OPRM1OPRK1MEN1KMT2A | |
| SCHEMBL29373629 | 0.89 | ECE1 (0.39) | MEN1KMT2AECE1 | |
| SCHEMBL29590467 | 0.89 | GRPR (0.39) | OPRD1OPRM1OPRK1F2 | |
| SCHEMBL32677418 | 0.88 | SLC15A2 (0.43) | F2 | |
| SCHEMBL31590090 | 0.88 | OPRD1 (0.35) | OPRD1OPRM1OPRK1MEN1KMT2A | |
| SCHEMBL11028917 | 0.87 | OPRD1 (0.37) | OPRD1OPRM1OPRK1 | |
| SCHEMBL11028909 | 0.87 | OPRD1 (0.37) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29630518 | 0.87 | OPRD1 (0.37) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30504749 | 0.86 | OPRM1 (0.36) | OPRD1OPRM1OPRK1F2 | |
| SCHEMBL30192164 | 0.86 | BACE1 (0.36) | ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |